UltimEyes + Contour Integration Training for Schizophrenia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Schizophrenia+1 MoreUltimEyes + Contour Integration Training - Behavioral
Eligibility
18 - 60
All Sexes
What conditions do you have?
Select

Study Summary

This trial will evaluate the effectiveness of different interventions targeting visual functions that are often impaired in people with schizophrenia. The study will compare the effects of the interventions to a control condition of higher-level cognitive remediation. Outcome measures include multiple aspects of visual functioning, as well as visual cognition and overall community functioning.

Eligible Conditions
  • Schizophrenia
  • Schizoaffective Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 4 Secondary · Reporting Duration: Years 3-5

Years 1-5
Contour integration
Contrast sensitivity - behavioral
Contrast sensitivity - electrophysiological
Years 3-5
Cognition
Community functioning
Emotion recognition
Reading speed

Trial Safety

Safety Progress

1 of 3

Trial Design

4 Treatment Groups

Cognitive remediation
1 of 4
Contrast sensitivity + Perceptual org.
1 of 4
Contrast sensitivity
1 of 4
Perceptual organization
1 of 4

Active Control

Experimental Treatment

180 Total Participants · 4 Treatment Groups

Primary Treatment: UltimEyes + Contour Integration Training · No Placebo Group · N/A

Contrast sensitivity + Perceptual org.
Behavioral
Experimental Group · 1 Intervention: UltimEyes + Contour Integration Training · Intervention Types: Behavioral
Contrast sensitivity
Behavioral
Experimental Group · 1 Intervention: UltimEyes · Intervention Types: Behavioral
Perceptual organization
Behavioral
Experimental Group · 1 Intervention: Contour Integration Training · Intervention Types: Behavioral
Cognitive remediation
Behavioral
ActiveComparator Group · 1 Intervention: MyBrainSolutions · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: years 3-5

Who is running the clinical trial?

New York UniversityOTHER
205 Previous Clinical Trials
313,584 Total Patients Enrolled
University of RochesterLead Sponsor
791 Previous Clinical Trials
501,569 Total Patients Enrolled
1 Trials studying Schizophrenia
180 Patients Enrolled for Schizophrenia

Eligibility Criteria

Age 18 - 60 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must speak English.\n
You are able to complete the MCCB at the baseline assessment.